Reuters logo
BRIEF-BioDelivery Sciences announces approval of BUNAVAIL
May 2, 2017 / 11:21 AM / in 6 months

BRIEF-BioDelivery Sciences announces approval of BUNAVAIL

May 2 (Reuters) - Biodelivery Sciences International Inc

* Biodelivery sciences announces the approval of bunavail® for induction of buprenorphine treatment for opioid dependence

* Biodelivery sciences international - fda approved snda for bunavail revising indication to include use of bunavail for initiation of buprenorphine treatment for opioid dependence Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below